(BHVN) closed 7% higher on Wednesday on the heels of hitting enrollment milestones in two high-priority clinical programs, ...

Incubated by Houston-based Fannin Innovation Studio, the 11h drug created in Nebraska will move toward phase 1 clinical ...

Shares of Larimar Therapeutics, Inc. (LRMR) jumped 3% after hours on Wednesday after its director, Thomas E. Hamilton, ...

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ science, today announced the formal launch of the first drug candidate of NAD Pharmaceuticals Corp., its wholly owned subsidiary ...

Once rapidly fatal, neglected, and orphan diseases without approved therapeutic options, systemic amyloidoses are now highly ...

An international team has published a new guideline for diagnosing and treating the rare genetic disease. It serves as a tool ...

Oxygen isn't always a good thing. Of course, people-and most organisms-cannot live without it. But oxygen can also be quite ...

Pain remains one of the most prevalent and disabling non-motor consequences of neurological disease, yet it continues to be ...

Patients may not know that these treatments are experimental or about the risks they may pose. The latest in AJC's ...